Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-β signaling

被引:23
|
作者
Cummins, Timothy D. [1 ]
Barati, Michelle T. [2 ]
Coventry, Susan C. [3 ]
Salyer, Sarah A. [2 ]
Klein, Jon B. [1 ,2 ]
Powell, David W. [1 ,2 ]
机构
[1] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA
[2] Univ Louisville, Sch Med, Dept Med, Louisville, KY 40292 USA
[3] Univ Louisville, Sch Med, Dept Pathol, Louisville, KY 40292 USA
来源
基金
美国国家卫生研究院;
关键词
Proteomic; Mass spectrometry; TGF beta signaling; Fibrosis; Type I diabetes; STAGE RENAL-DISEASE; MYOFIBROBLAST TRANSITION; GLUCOKINASE MUTATIONS; GLUCOSE-HOMEOSTASIS; PROTEIN EXPRESSION; ADAPTER PROTEINS; GENE-PROMOTER; FACTOR-I; MICE; RECEPTOR;
D O I
10.1016/j.bbapap.2009.09.029
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this study was to define novel mediators Of tubule injury in diabetic kidney disease. For this, we used state-of-the-art proteomic methods combined with a label-free quantitative strategy to define protein expression differences in kidney tubules from transgenic OVE26 type I diabetic and control mice. The analysis was performed with diabetic samples that displayed a pro-fibrotic phenotype. We have identified 476 differentially expressed proteins. Bioinformatic analysis indicated several clusters of regulated proteins in relevant functional groups Such as TGF-beta signaling, tight junction maintenance, oxidative stress, and glucose metabolism. Mass spectrometry detected expression changes of four physiologically relevant proteins were confirmed by immunoblot analysis. Of these, the Grb2-related adaptor protein (GRAP) was up-regulated in kidney tubules from diabetic mice and fibrotic kidneys from diabetic patients, and subsequently confirmed as a novel component of TGF-beta signaling in cultured human renal tubule cells. Thus, indicating a potential novel role for GRAP in TGF-beta-induced tubule injury in diabetic kidney disease. Although we targeted a specific disease, this approach offers a robust, high-sensitivity methodology that can be applied to the discovery of novel mediators for any experimental or disease condition. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:653 / 661
页数:9
相关论文
共 33 条
  • [1] TGF-β in diabetic kidney disease:: role of novel signaling pathways
    Sharma, K
    McGowan, TA
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2000, 11 (1-2) : 115 - 123
  • [2] microRNA Regulatory Network Inference Identifies miR-34a as a Novel Regulator of TGF-β Signaling in Glioblastoma
    Genovese, Giannicola
    Ergun, Ayla
    Shukla, Sachet A.
    Campos, Benito
    Hanna, Jason
    Ghosh, Papia
    Quayle, Steven N.
    Rai, Kunal
    Colla, Simona
    Ying, Haoqiang
    Wu, Chang-Jiun
    Sarkar, Sharmistha
    Xiao, Yonghong
    Zhang, Jianhua
    Zhang, Hailei
    Kwong, Lawrence
    Dunn, Katherine
    Wiedemeyer, Wolf Ruprecht
    Brennan, Cameron
    Zheng, Hongwu
    Rimm, David L.
    Collins, James J.
    Chin, Lynda
    [J]. CANCER DISCOVERY, 2012, 2 (08) : 736 - 749
  • [3] CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling
    Xiong, Xiangyang
    Tu, Shuo
    Wang, Jianbin
    Luo, Shiwen
    Yan, Xiaohua
    [J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2019, 23 (02) : 740 - 749
  • [4] Studying TGF-β Signaling Using a High Resolution, Quantitative Mass Spectrometric Approach
    D'Souza, R. C. J.
    Sharma, K.
    Korhonen, A. M. M.
    Nagaraj, N.
    Choudhary, C.
    ten Dijke, P.
    Mann, M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2012, 48 : S155 - S155
  • [5] Quantitative mass spectrometry identifies insulin signaling targets in C-elegans
    Dong, Meng-Qiu
    Venable, John D.
    Au, Nora
    Xu, Tao
    Park, Sung Kyu
    Cociorva, Daniel
    Johnson, Jeffrey R.
    Dillin, Andrew
    Yates, John R., III
    [J]. SCIENCE, 2007, 317 (5838) : 660 - 663
  • [6] SnoN as a novel negative regulator of TGF-β/Smad signaling: a target for tailoring organ fibrosis
    Zeglinski, Matthew R.
    Hnatowich, Mark
    Jassal, Davinder S.
    Dixon, Ian M. C.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2015, 308 (02): : H75 - H82
  • [7] Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer
    Witte, David
    Zeeh, Franziska
    Gaedeken, Thomas
    Gieseler, Frank
    Rauch, Bernhard H.
    Settmacher, Utz
    Kaufmann, Roland
    Lehnert, Hendrik
    Ungefroren, Hendrik
    [J]. JOURNAL OF CLINICAL MEDICINE, 2016, 5 (12):
  • [8] SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner
    Nagasaka, Mai
    Inoue, Yasumichi
    Nagao, Yuji
    Miyajima, Chiharu
    Morishita, Daisuke
    Aoki, Hiromasa
    Aoyama, Mineyoshi
    Imamura, Takeshi
    Hayashi, Hidetoshi
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
  • [9] SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner
    Mai Nagasaka
    Yasumichi Inoue
    Yuji Nagao
    Chiharu Miyajima
    Daisuke Morishita
    Hiromasa Aoki
    Mineyoshi Aoyama
    Takeshi Imamura
    Hidetoshi Hayashi
    [J]. Scientific Reports, 13
  • [10] A Quantitative RNAi Screen for JNK Modifiers Identifies Pvr as a Novel Regulator of Drosophila Immune Signaling
    Bond, David
    Foley, Edan
    [J]. PLOS PATHOGENS, 2009, 5 (11)